Target intelligence / Profile preview

Antimicrobial peptide (AMP) (AMP)

Target
AMP
Molecular classification
Other (general host-defense effector), Peptide (short protein fragment), Ribosomally synthesized peptide (RAMP), Non-ribosomally synthesized peptide, Bacteriocin, Lantibiotic, Defensin, Cathelicidin, Histatin
01

Overview

Antimicrobial peptides (AMPs) are short, typically cationic peptides found in all classes of life as critical components of the innate immune response. They act as broad-spectrum anti-infectives and exhibit activities against bacteria, fungi, viruses, and parasites, sometimes also showing anti-tumor effects. Their primary mechanisms include disrupting microbial membranes, inhibiting synthesis of macromolecules, and modulating immune responses. They are structurally diverse and classified by sequence, source, 3D structure, and biosynthetic mechanisms. While numerous antimicrobial peptides are clinically or experimentally relevant, "antimicrobial proteins" is a generic term that encompasses many molecules, some of which may be developed as therapeutics, but is not itself a drug target, receptor, or gene product.

Other names
Host defense peptides (HDPs)Antimicrobial host peptidesCationic peptidesDefensinCathelicidinHistatinCecropinMagaininBacteriocinLantibiotic
02

Mechanism of action

Membrane disruption and cell lysis ("carpet," "barrel-stave," "toroidal-pore," "disordered toroidal-pore" models); Inhibition of cell wall synthesis; Inhibition of DNA, RNA, and protein synthesis; Activation of autolysins and other cell death pathways; Immune modulation (chemotaxis, induction of cytokines)

03

Biological functions

Immune response (innate immunity)Direct microbicidal activityImmune modulationInhibition of bacterial and fungal proliferationAnti-tumor activity (some members)Angiogenesis and wound healing (some members)
04

Disease associations

Infection (bacterial, fungal, viral, parasitic)Cancer (some AMPs are cytotoxic to cancer cells)Inflammation/autoimmune disorders (immunomodulatory roles)Other (skin disorders such as psoriasis, oral diseases, wound healing)
05

Safety considerations

Cytotoxicity at high doses (can damage host cells)Immunogenicity (some AMPs may trigger immune responses)Resistance development (bacterial adaptation)Short plasma half-life and rapid degradationPoor pharmacokinetic properties (for peptide drugs)
06

Interacting drugs

No traditional small-molecule drugs—the AMPs themselves are often therapeutically developed

7 more in the full profile.

07

Biomarkers

Levels of specific AMPs (e.g., human defensins, LL-37, psoriasin) may serve as infection, inflammation, or disease activity biomarkers in clinical and research settingsNo generic "antimicrobial protein" biomarker

Beyond the preview

Go deeper on Antimicrobial peptide (AMP) (AMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antimicrobial peptide (AMP) (AMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call